Head-To-Head Contrast: Insulet (NASDAQ:PODD) and Eagleford Energy (OTCMKTS:GRUSF)

Eagleford Energy (OTCMKTS:GRUSF) and Insulet (NASDAQ:PODD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Eagleford Energy and Insulet, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eagleford Energy	0	0	0	0	0.00
Insulet	0	2	22	1	2.96

Insulet has a consensus target price of $379.00, suggesting a potential upside of 31.89%. Given Insulet’s stronger consensus rating and higher possible upside, analysts plainly believe Insulet is more favorable than Eagleford Energy.

Institutional and Insider Ownership

9.3% of Eagleford Energy shares are held by institutional investors. 23.2% of Eagleford Energy shares are held by company insiders. Comparatively, 0.4% of Insulet shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Eagleford Energy and Insulet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Eagleford Energy	31.81%	28.90%	14.38%
Insulet	9.76%	24.36%	10.02%

Earnings and Valuation

This table compares Eagleford Energy and Insulet”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eagleford Energy	$27.02 million	3.55	-$11.30 million	$0.02	23.00
Insulet	$2.07 billion	9.76	$418.30 million	$3.45	83.29

Insulet has higher revenue and earnings than Eagleford Energy. Eagleford Energy is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Summary

Insulet beats Eagleford Energy on 9 of the 14 factors compared between the two stocks.

About Eagleford Energy

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors. Grown Rogue International Inc. is headquartered in Medford, Oregon.

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.